Future-Proof Your Gene Therapy

To meet the demand of this rapidly growing industry, we set ambitious goals to provide competent capacity and capabilities, investing in, building and ultimately deploying best-in-class viral vector manufacturing platforms that incorporate cutting-edge technologies.

In addition to providing our partners with viral vectors (AAV and LVV) and esoteric viruses, we have built the requisite Process and Analytical Development (PAD) and GMP services, capacity and viral vector platforms which aim to enable these life-saving gene therapies to get to the clinic and to commercialization more quickly.

Join our partners who are already taking advantage of our best-in-class viral vector PAD and GMP biomanufacturing network.